/Preparation Of Substituted 1,2-diaminoheterocyclic Compound Derivatives And Their Use As Pharmaceutical Agents
Abstract
This invention relates to compounds which are microtubule associated serine/threonine-like kinase (MASTL) inhibitors and the use of the compounds in the treatment of diseases and medical conditions mediated by MASTL, for example in the treatment of cancer and other target related diseases.
Full Text
What is claimed is:
This invention relates to compounds which are microtubule associated serine/threonine-like kinase (MASTL) inhibitors and the use of the compounds in the treatment of diseases and medical conditions mediated by MASTL, for example in the treatment of cancer and other target related diseases.
Timeline
Filed
04/20/2026Published
08/27/2026Granted
Not AvailableIPC Codes(12)
C07D 413/14:containing three or more hetero rings
A61K 31/506:not condensed and containing further heterocyclic rings
A61K 31/53:having six-membered rings with three nitrogens as the only ring hetero atoms, e.g. chlorazanil, melamine (melarsoprol A61K 31/555)